Shanghai Yutong Pharmaceuticals

Shanghai Yutong Pharmaceuticals (now operating as ANBC, Inc.) is a pharmaceutical and healthcare company based in Shanghai, China, specializing in the development, manufacturing, and commercialization of traditional Chinese herbal medicines and biological pharmaceuticals. The company's product portfolio includes a variety of oral solutions and syrups, such as Qilisheng for immune system enhancement and Qi-ju-di-huang for kidney and liver protection. Following a reverse merger in 2005 and a subsequent name change in 2017, the company expanded its operations into the nutraceutical sector, producing Omega 3 capsules and food additives through its subsidiary, Shanghai Niubeile Biotechnology. Its manufacturing facilities are GMP-certified, and the company primarily serves the Chinese domestic market while also engaging in international exports.